This inventor holds 2 USPTO granted patents. Top assignees: Glycart Biotechnology Ag, Roche Glycart Ag. Active years: 2009-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2011
Title: M Sean Bailey: Innovator in Antibody Glycosylation Engineering
Introduction
M Sean Bailey is a notable inventor and legal representative based in Santa Monica, California. He has made significant contributions in the field of glycosylation engineering, particularly focusing on the enhancement of therapeutic properties in antibodies. With two patents to his name, his work addresses critical advancements in cancer treatment and other therapeutic applications.
Latest Patents
M Sean Bailey holds two significant patents that emphasize his expertise in glycosylation engineering:
1. **Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity**: This invention pertains to the engineering of proteins, particularly antibodies, to improve their therapeutic effectiveness by enhancing their ability to mediate cellular cytotoxicity.
2. **Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity**: This patent also focuses on glycosylation engineering, aimed at improving the therapeutic properties of proteins, such as antibodies and antibody fragments, through enhanced Fc-mediated cellular cytotoxicity.
Career Highlights
Throughout his career, M Sean Bailey has worked with prominent companies in the biotechnology sector, including Glycart Biotechnology AG and Roche Glycart AG. His roles in these organizations have allowed him to collaborate on groundbreaking research in the field of antibody therapies.
Collaborations
Sean has collaborated with notable colleagues, including Pablo Umaña and Joël Jean-Mairet. These partnerships have proven instrumental in advancing the research and development of glycosylation-related therapies.
Conclusion
In summary, M Sean Bailey's contributions to the field of glycosylation engineering stand as a testament to his innovative spirit and commitment to improving therapeutic outcomes. His work continues to play a critical role in the development of enhanced antibody therapies, showcasing his influence in the biotechnology landscape.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile